Search

everythinglearnresearchcommunity

for

Search:↓

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Potential therapeutic targets for scarring hair loss are identified.

Chemokine signaling is important for hair development.

CXCL12+ fibroblasts help recruit neutrophils to fight skin infections.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

CXCR2 in skin cells promotes tumor growth.

A high-fat diet worsens neutrophilic folliculitis by increasing certain chemokines.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Regulatory T cells help hair growth by using the Cxcr4-Cxcl12 pathway.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Tph cells are linked to the severity of systemic lupus erythematosus.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

Notch1 helps skin heal by attracting specific immune cells.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Sun-exposed skin shows different cell activity and gene expression, suggesting targets to prevent skin aging and cancer.

Antibody treatments show promise for hair loss but need more research.

Activating Notch signaling can kill basal cell carcinoma cells.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

Granulocyte colony stimulating factor helps heal wounds without scars.

SDF-1/CXCL12 and its receptor CXCR4 are crucial for melanocyte movement in mouse hair follicles.

The right cells and signals can potentially lead to scarless wound healing, with a mix of natural and external wound healing controllers possibly being the best way to achieve this.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Finding functions for unknown GPCRs is hard but key for making new drugs.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.

Hedgehog pathway inhibitors could be effective in treating melanoma.